A major discovery in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in various kinds of tumors, leading https://bookmarkingdelta.com/story21910714/mini-antibodies-revive-tumor-suppressor-p53-a-potential-approach-for-malignant-treatment